Company Overview and News

5
Billion-Dollar Unicorns: FireEye Targets A Profitable Year

2018-09-20 seekingalpha - 2
It expects to continue with the performance and is on track to deliver non-GAAP profitability and positive free cash flow for 2018.
FEYE PANW MSFT ORCL

1
Chinese Cyber Spies Target Taiwan's Leader Before Elections

2018-09-19 theedgemarkets
(Sept 20): Taiwan is bracing for an onslaught of cyber attacks from mainland China ahead of local elections in November intended to undermine a president who has defied Beijing’s efforts to bring the democratically ruled island under its control.
FEYE

3
Short Sellers Hike Their Bets in Cybersecurity Stocks

2018-09-13 247wallst
Cybersecurity has become an increasingly important issue that companies have to address as they continue to develop new platforms and mobile apps. Hackers have been able to steal credit card and personal information from major companies like Equifax, JPMorgan and Home Depot. As a result, cybersecurity has become more necessary, and instead of developing a dedicated department within a company, most opt to hire a third-party cybersecurity firm.
CYBR HD FEYE PANW CHKP FTNT

3
FireEye Inc. (FEYE) Management on Deutsche Bank 2018 Technology Conference (Transcript)

2018-09-12 seekingalpha
Hi everyone. Thanks for coming to our Tech Conference. My name is Gray Powell, I cover Security and Infrastructure Software at Deutsche Bank. Today, we're very happy to have FireEye presenting with us at the conference. We have Frank Verdecanna, CFO. So, Frank, thanks for coming.
DB FEYE CBLK

2
FireEye: A Closer Look

2018-09-11 seekingalpha
Sluggish price action is a good sign that we need to revisit our forecast on this cyber play.
PFPT FEYE FTNT

1
FireEye: Getting Profitable With Tougher Competition?

2018-09-10 seekingalpha
FireEye is expanding out of its niche market. But the company does not have the portfolio to compete with established security vendors.
FEYE

6
FireEye, Inc. (FEYE) Presents at 2018 Citi Global Technology Conference (Transcript)

2018-09-09 seekingalpha - 3
So, again, I’m Walter Pritchard, the Software Analyst here at Citi. Happy to have FireEye here with us at 11:00 o’clock. We’ve got Frank Verdecanna, who is the CFO. And we’ve got Grady Summers, who is the CTO. So, as I’ve done in these prior sessions, I’ll run through some questions that we’ve prepared. And then, to the extent there are any questions out here in the room, feel free to raise your hand.
FEYE CBLK

24
The Ratings Game: Okta, Palo Alto Networks highs drive cybersecurity gains on anniversary of Equifax hack disclosure

2018-09-07 marketwatch
Cybersecurity stocks rose Friday following strong earnings from Okta Inc. and Palo Alto Networks Inc., adding to solid gains over the past year following the disclosure of a massive data breach at Equifax Inc.
EVBG SPLK SYMC VRNS EFX ZS PANW CHKP CYBR FEYE IMPV OKTA JNPR QLYS FTNT

1
In One Chart: The Equifax data breach, in one chart

2018-09-07 marketwatch
A year after hack was first disclosed, stock is down 4% while revenue is on the rise
FEYE EFX

13
A year after Equifax, cybersecurity is still seeking its Holy Grail

2018-09-07 marketwatch - 1
Security software is a fractured industry in need of consolidation to address growing needs, executives say
IBM HGRL FEYE EFX SAIL ZS WDAY OCLCF CBLK TENB CSCO ORCL

2
6 Cybersecurity Stocks in Focus as Hacking Threatens Elections

2018-09-07 investorplace
Growing sophistication of cyber-attacks and repeated attempts at high-profile hacking have kept countries around the globe alert over the past few years. A series of cyber-attacks like WannaCry or WannaCrypt ransomware attacks and Petya rocked the globe.
PFPT FEYE PANW FTNT

158
Tracking Chase Coleman's Tiger Global Portfolio - Q2 2018 Update

2018-09-05 seekingalpha - 6
The largest three positions are Spotify, Amazon.com, and JD.com, and they add up to ~30% of the portfolio.
RDFN BCS NOW HUYA REDU FPI CRM QSR.WI SOGO 83SF FEYE AMZN 83SK TWTR MELI SWCH TEAM PSTG COUP BILI CLDR MSFT JD FB FIT LC MDB DOCU NFLX APO ADBE DESP DBX OKTA QSR 47MC SHOP NETS TDG RUN ZTO MA PVTL AVLR V BKNG IQ ADSK FLT

1
Why Is FireEye (FEYE) Up 6.4% Since Last Earnings Report?

2018-09-01 zacks
It has been about a month since the last earnings report for FireEye (FEYE - Free Report) . Shares have added about 6.4% in that time frame, outperforming the S&P 500.
FEYE

1
Iran-based political influence operation: Bigger, persistent, global

2018-08-29 channelnewsasia
LONDON/WASHINGTON: An apparent Iranian influence operation targeting internet users worldwide is significantly bigger than previously identified, Reuters has found, encompassing a sprawling network of anonymous websites and social media accounts in 11 different languages.
FEYE

13
Exclusive: Iran-based political influence operation: bigger, persistent, global

2018-08-29 channelnewsasia
An apparent Iranian influence operation targeting internet users worldwide is significantly bigger than previously identified, Reuters has found, encompassing a sprawling network of anonymous websites and social media accounts in 11 different languages.
FB FEYE GOOGL TWTR GOOG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to FEYE / FireEye, Inc. on message board site Silicon Investor.

FireEye, Inc. (FEYE) - cybersecurity FireEye, Inc. (FEYE) - cybersecurity FireEye, Inc. (FEYE) - cybersecurity
CUSIP: 31816Q101